Phase II Trial of Salvage Radiation Therapy for Prostate Cancer in Four Weeks Versus Five Days (SHORTER)

Details

Weill Cornell is leading a randomized Phase II trial of salvage radiation therapy for prostate cancer in four weeks versus five days. The purpose of this trial is to compare the side effects of longer and shorter courses of radiation. Five days of treatment is a new option currently being studied in this trial with real-time MRI guidance. Related Content: ClinicalTrials.gov Identifier: NCT04422132...